Skip to main content

Acute Delirium After Ketamine Infusion for Chronic Pain

  • Chapter
  • First Online:
Challenging Cases and Complication Management in Pain Medicine

Abstract

Unlike acute pain, chronic pain is hard to manage and is resistant to many interventions. The N-methyl-d-aspartate (NMDA) receptor is key in chronic pain, making it a prime target for treatment. Ketamine is the most commonly used NMDA antagonist used in the management of chronic pain. A short-term infusion of ketamine produces potent analgesia during administration. Some studies of prolonged infusion (4–14 days) show long-term analgesic effects up to 3 months. The common adverse effects of ketamine reported in clinical studies are nervous system symptoms (hallucinations, memory defects, panic attacks, somnolence), gastrointestinal symptoms (nausea/vomiting), cardiovascular stimulation, and, in a few cases, liver failure. In a clinical setting, ketamine is well tolerated, especially when benzodiazepines are used to prevent its psychotropic effects. In monitoring patients receiving ketamine, the focus is on central nervous system or hemodynamic changes during infusion, hepatic function, and the potential for abuse on repeated administration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. J Pain. 2015;16(8):769–80.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Dworkin RH, O’Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85:S3–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence-based proposal. Pain. 2005;118:289–305.

    Article  CAS  PubMed  Google Scholar 

  4. Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth Analg. 2003;97:1108–16.

    Article  CAS  PubMed  Google Scholar 

  5. Marchand F, Perretti M, McMahon SB. Role of immune system in chronic pain. Nat Rev Neurosci. 2005;6:521–32.

    Article  CAS  PubMed  Google Scholar 

  6. Dahan A, Olofsen E, Sigtermans M, et al. Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain. Eur J Pain. 2011;15:258–6.

    Article  CAS  PubMed  Google Scholar 

  7. Domino EF. Taming the ketamine tiger. Anesthesiology. 2010;113:876–86.

    Google Scholar 

  8. Hijazi Y, Boulieu R. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos. 2002;30:853–8.

    Article  CAS  PubMed  Google Scholar 

  9. Olofsen E, Noppers I, Niesters M, Kharasch E, Aarts L, Sarton E. Estimation of the contribution of norketamine to ketamine-induced acute pain relief and neurocognitive impairment in healthy volunteers. Anesthesiology. 2012;117:353–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Patil S, Anitescu M. Efficacy of outpatient ketamine infusion in refractory chronic pain syndromes: a 5 year retrospective analysis. Pain Med. 2012;13(2):263–9.

    Article  PubMed  Google Scholar 

  11. Bowdle AT, Radant AD, Cowley DS, Kharash ED, Strassman RJ, Ray-Byrne PP. Psychedelic effects of ketamine in healthy volunteers. Anesthesiology. 1998;88:82–8.

    Google Scholar 

  12. Pomarol-Clotet E, Honey GD, Murray GK, et al. Psychological effects of ketamine in healthy volunteers. Phenomenological study. Br J Psychiatry. 2006;189:173–9.

    Article  CAS  PubMed  Google Scholar 

  13. Cverck P. Side effect of ketamine in the long-term treatment of neuropathic pain. Pain Med. 2008;9:253–7.

    Article  Google Scholar 

  14. Bergman SA. Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog. 1999;46:10–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Sigtermans M, Dahan A, Mooren R, et al. S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers. Anesthesiology. 2009;111:892–903.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tariq Malik M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Malik, T. (2018). Acute Delirium After Ketamine Infusion for Chronic Pain. In: Anitescu, M., Benzon, H., Wallace, M. (eds) Challenging Cases and Complication Management in Pain Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-60072-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-60072-7_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-60070-3

  • Online ISBN: 978-3-319-60072-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics